Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06012123
Other study ID # PI23-0005
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 1, 2023
Est. completion date August 15, 2023

Study information

Verified date August 2023
Source Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

The covered endovascular reconstruction of aortic bifurcation (CERAB) technique was described l in 2013 to reconstruct the aortic bifurcation in a more anatomical and physiological way. With the use of this technique, a covered stent is expanded 15 to 20 mm above the aortic bifurcation and this stent is proximally adapted to the aortic wall with a larger balloon, thereby creating a cone-shaped stent. Two iliac covered stents are then placed in the distal conic segment and simultaneously inflated, making a tight connection with the aortic stent, as if they were molded together, thus simulating a new bifurcation. This minimal invasive endovascular technique using covered stents, was developed in order to optimize endovascular mimicking the anatomical configuration of the aortic bifurcation and in an attempt to overcome the disadvantages of kissing stents influenced by geometric factors such as radial mismatch, protrusion mismatch and stent conformation. The use of BeGraft (balloon-expandalbe covered stent) and Solaris (self-expandable covered stent) fro this technique is revised.


Description:

The covered endovascular reconstruction of aortic bifurcation (CERAB) technique was described l in 2013 to reconstruct the aortic bifurcation in a more anatomical and physiological way. With the use of this technique, a covered stent is expanded 15 to 20 mm above the aortic bifurcation and this stent is proximally adapted to the aortic wall with a larger balloon, thereby creating a cone-shaped stent. Two iliac covered stents are then placed in the distal conic segment and simultaneously inflated, making a tight connection with the aortic stent, as if they were molded together, thus simulating a new bifurcation. This minimal invasive endovascular technique using covered stents, was developed in order to optimize endovascular mimicking the anatomical configuration of the aortic bifurcation and in an attempt to overcome the disadvantages of kissing stents influenced by geometric factors such as radial mismatch, protrusion mismatch and stent conformation. The use of BeGraft (balloon-expandalbe covered stent) and Solaris (self-expandable covered stent) fro this technique is revised. A retrospective study included patients that underwent endovascular treatment of atherosclerotic steno-occlusive aorto-iliac lesions between January 2020 and June 2023. The study, which received no financial support from industry, was performed in agreement with the Declaration of Helsinki and was approved by our institutional review boards. In accordance with institutional and local regulatory policies, this retrospective review of de-identified procedural and follow-up data was exempt from informed consent.


Recruitment information / eligibility

Status Completed
Enrollment 21
Est. completion date August 15, 2023
Est. primary completion date July 30, 2023
Accepts healthy volunteers No
Gender All
Age group N/A to 100 Years
Eligibility Inclusion Criteria: - Patients with lifestyle-limiting intermittent claudication, ischemic rest pain, ischemic ulcers or gangrene (Rutherford class 3 to 6) who presented steno-occlusive disease of the aortic bifurcation undergoing endovascular treatment by CERAB and PTA/covered stenting of iliac arteries Exclusion Criteria: - Patients who could not receive antiplatelet or anticoagulation therapies. - Patients with concomitant aneurysm of the aorta, acute thrombus, unsalvageable limb or very limited life-expectancy.

Study Design


Intervention

Procedure:
Aortoiliac angioplasty and stenting
Covered endovascular reconstruction of aortic bifurcation (CERAB) in patient with aorto-iliac occlusive disease

Locations

Country Name City State
Spain Valladolid Univeristy Hospital Valladolid

Sponsors (1)

Lead Sponsor Collaborator
Vascular Investigation Network Spanish Society for Angiology and Vascular Surgery

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Primary patency Absence of binary restenosis or reocclusion on duplex ultrasound examination without repeat target lesion interventions 12 months
Secondary Primary-assisted patency Patent aoto-iliac segment that underwent further intervention within the inflow, treated vessel segment, or outflow of the treated vessel segment to improve patency 12 months
Secondary Secondary patency Requiring a secondary intervention to restore patency after occlusion of the treated segment. Secondary interventions include PTA, drug-eluting balloon PTA (DEB-PTA), additional stent placement or surgical bypass based on clinical deterioration. 12 months
Secondary Mortality 12 months
Secondary Amputation rate Major and minor amputation rate 12 months
Secondary Clinical status Rutherford scale 12 months
Secondary ABI measurements Ankle-Brachial index 12 months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04023370 - Evaluation of the Efficacy and Safety of the Application of BeGraft Peripheral Stent Graft System N/A
Not yet recruiting NCT04175197 - LegDeb2 Global Registry for Use of Legflow in Peripheral Arteries
Completed NCT00896337 - EPIC Nitinol Stent System in the Treatment of Atherosclerotic Lesions in Iliac Arteries Phase 3
Active, not recruiting NCT04299906 - SOLARIS Peripheral PMCF Trial N/A
Recruiting NCT03687983 - Safety and Efficacy Study of GoldenFlow Peripheral Stent System N/A
Not yet recruiting NCT05229250 - NIRS and Exercise Intensity in Patients With FLIA
Not yet recruiting NCT05377775 - Mesh Stents Study in ILIAC Complex Lesions (IMS-Study) N/A
Not yet recruiting NCT04545281 - Physician-Initiated PMCF Trial Investigating the Solaris Vascular Stent Graft for the Treatment of Iliac Lesions Phase 4
Recruiting NCT04714268 - Comparison of Aorto-iliac Endovascular Interventions With and Without the EndoNaut Workstation
Recruiting NCT02793492 - Misago® RX Self-expanding Peripheral Stent for Common and/or External Iliac Artery N/A
Enrolling by invitation NCT05117515 - Retrospective Study of the Uni-Graft® K DV Patch in the Clinical Routine
Completed NCT04343196 - Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction N/A
Completed NCT03844724 - Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion N/A